Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literature
- PMID: 38570871
- PMCID: PMC10993550
- DOI: 10.1186/s13256-024-04463-w
Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literature
Abstract
Background: The activity level of alkaline phosphatase, a zinc-requiring enzyme in the serum, is used to indicate zinc nutritional status; however, it does not correlate with serum zinc levels or subjective symptoms of taste disorder in many cases. Hence, this study focused on the total activity of alkaline phosphatase, a zinc-requiring enzyme. The total alkaline phosphatasa activity level in the saliva was measured before and after zinc supplementation, and the results were compared with serum zinc levels.
Case presentation: This study included patients with hypozincemia, specifically a patient with zinc-deficient taste disorder (patient 1: a 69-year-old Japanese woman) and a patient with glossodynia with zinc deficiency (patient 2: an 82-year-old Japanese woman). Saliva samples were collected, and blood tests were performed before and after zinc supplementation. Subjective symptoms and serum zinc levels were simultaneously evaluated. Zinc supplementation was performed using zinc acetate hydrate or Polaprezinc.
Conclusions: Total alkaline phosphatase activity levels were found to be associated with serum zinc levels and subjective symptoms. A further study with a higher number of patients is necessary to confirm whether total alkaline phosphatase activity levels more accurately reflect the amounts of zinc in the body than serum zinc levels.
Keywords: Saliva; Serum zinc; Total ALP activity; Zinc-metabolizing enzymes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Interventions for managing taste disturbances.Cochrane Database Syst Rev. 2017 Dec 20;12(12):CD010470. doi: 10.1002/14651858.CD010470.pub3. Cochrane Database Syst Rev. 2017. PMID: 29260510 Free PMC article.
-
Interventions for the management of taste disturbances.Cochrane Database Syst Rev. 2014 Nov 26;(11):CD010470. doi: 10.1002/14651858.CD010470.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Dec 20;12:CD010470. doi: 10.1002/14651858.CD010470.pub3. PMID: 25425011 Updated.
-
Zinc supplements for treating thalassaemia and sickle cell disease.Cochrane Database Syst Rev. 2013 Jun 28;2013(6):CD009415. doi: 10.1002/14651858.CD009415.pub2. Cochrane Database Syst Rev. 2013. PMID: 23807756 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
Cited by
-
Patients with Taste Disorders in a Hospital's Dental Department and Strategies for Taste Disorders.Biomedicines. 2024 Sep 23;12(9):2160. doi: 10.3390/biomedicines12092160. Biomedicines. 2024. PMID: 39335673 Free PMC article.
References
-
- Yutaka Y, Ken-Ichiro S, Jun S, Manabu O, Hironobu H, Atsushi M. Clinical study of 210 cases of taste disorder. J Jpn Stomatol Soc. 2013;62:247–253.
-
- Ohga N, Yamazaki Y, Sato J, Hata H, Murata T, Sakata K, et al. Dose escalation effectiveness and tolerability of paroxetine in patients with burning mouth syndrome and depressive conditions. J Oral Maxillofac Surg Med Pathol. 2015;27:402–406. doi: 10.1016/j.ajoms.2015.02.001. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources